tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Yatin Suneja, 217 are a BUY (88.57%), 28 are a HOLD (11.43%).
Analyst Yatin Suneja, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 46.77% that have a potential upside of 48.1% achieved within 271 days.
Yatin Suneja’s has documented 471 price targets and ratings displayed on 48 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BIIB, Biogen at 10-Feb-2026.
Analyst best performing recommendations are on IMVT (IMMUNOVANT ).
The best stock recommendation documented was for IMVT (IMMUNOVANT ) at 9/22/2023. The price target of $32 was fulfilled within 4 days with a profit of $11.61 (56.94%) receiving and performance score of 142.35.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 08-Dec-2021
$23
$0.97 (4.40%)
$22
10 days ago
(06-Feb-2026)
17/17 (100%)
$-0.46 (-1.96%)
84
Buy Since 26-Jun-2025
$31
$8.97 (40.72%)
$32
13 days ago
(03-Feb-2026)
0/5 (0%)
$4.87 (18.64%)
Buy Since 21-Oct-2025
$36
$13.97 (63.41%)
$33
1 months 10 days ago
(06-Jan-2026)
0/2 (0%)
$9.06 (33.63%)
Buy Since 17-Oct-2023
$40
$17.97 (81.57%)
$39
1 months 10 days ago
(06-Jan-2026)
2/7 (28.57%)
$13.06 (48.48%)
467
Hold Since 03-Nov-2022
$25
$2.97 (13.48%)
2 months 5 days ago
(11-Dec-2025)
18/21 (85.71%)
$-1.68 (-6.30%)
118
Which stock is Yatin Suneja is most bullish on?
Which stock is Yatin Suneja is most reserved on?
What Year was the first public recommendation made by Yatin Suneja?
